Read or listen to CERA's 2024 Annual Review, which recognises the scientists, supporters, research partners, funders and people with vision loss who all play in role in helping us develop new ways to detect and treat eye diseases, prevent blindness and restore sight.
Our new Consumer Program is working alongside people with lived experience to ensure their insights are at the heart of advancing eye research.
Learn about the program and meet our Consumer Advisory Group.
The Centre for Eye Research Australia has announced key scientific appointments to boost its glaucoma and inherited retinal disease research programs in 2026.
CERA’s Founding Managing Director Professor Hugh R Taylor AC has spent decades protecting vision by bridging the lab and the clinic. His new autobiography captures that journey.
Cell reprogramming spin-out company Mirugen has secured up to $AUD 4.5M in seed funding from a consortium of investors to advance research into a treatment for the incurable genetic eye disease retinitis pigmentosa.
